[EXECUTION VERSION AMENDMENT NO. 3 TO RIGHTS AGREEMENT Amendment Rights Agreement Company Rights Agent AMENDMENT NO. 3 (this “ WHEREAS, the Board of Directors desires to amend the Rights Agreement as set forth herein; WHEREAS, the Flip-In Date has not occurred; WHEREAS, the Special Committee has appr]

[iKang Enters into Definitive Merger Agreement for Going Private Transaction BEIJING, March 26, 2018 — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), Immediately following the consummation of the merger, Parent will be beneficially owned by the Sponsors, Mr. Lee Ligang Zhang,]

[iKang Announces Unaudited Financial Results for the Fiscal Third Quarter Ended December 31, 2017 BEIJING, MARCH 22, 2018 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), major provider in China’s fast growing private preventive healthcare services market, to]

[iKang Announces Receipt of Proposal from Yunfeng Capital and Alibaba BEIJING, March 12, 2018 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), The Special Committee has received a proposal from Yunfeng and Alibaba Investment Limited (“Alibaba”), proposing a t]